Skip to content
Screener

Atara Biotherapeutics ATRA Q2 2026 earnings

Reported August 12, 2026 · After market close

Revenue$630.0KBeat by $80.0K
EPS-$0.32Miss by $0.01
Revenue estimate$550.0K
EPS estimate-$0.32

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$800.0K
EPS estimate-$0.13

FAQ

When did Atara Biotherapeutics report Q2 2026 earnings?
Atara Biotherapeutics (ATRA) reported Q2 2026 earnings on August 12, 2026 after market close.
What were Atara Biotherapeutics's Q2 2026 revenue and EPS?
Atara Biotherapeutics reported revenue of $630.0K and eps of $-0.32 for Q2 2026.
Did Atara Biotherapeutics beat estimates in Q2 2026?
Revenue beat the consensus estimate of $550.0K by $80.0K. EPS missed the consensus estimate of $-0.32 by $0.01.
How did Atara Biotherapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 96.4% from $17.6M a year earlier.
Where can I find Atara Biotherapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-346857) and the 10-Q periodic report (0001193125-26-346885) directly on SEC EDGAR. The filing index links above go to sec.gov.